Security Snapshot

Elanco Animal Health Inc - Common Stock (ELAN) Institutional Ownership

CUSIP: 28414H103

13F Institutional Holders and Ownership History from Q1 2016 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

479

Shares (Excl. Options)

539,036,951

Price

$22.63

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Common Stock
Symbol
ELAN on NYSE
Shares outstanding
500,553,776
Price per share
$23.93
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
539,036,951
Total reported value
$12,199,052,360
% of total 13F portfolios
0.01%
Share change
-34,638,679
Value change
-$765,097,720
Number of holders
479
Price from insider filings
$23.93
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • ELAN - Elanco Animal Health Inc - Common Stock is tracked under CUSIP 28414H103.
  • 479 institutions reported positions in Q4 2025.
  • 5 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 479 to 84 between Q4 2025 and Q1 2026.
  • Reported value moved from $12,199,052,360 to $203,248,851.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 479 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 28414H103?
CUSIP 28414H103 identifies ELAN - Elanco Animal Health Inc - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Elanco Animal Health Inc - Common Stock (ELAN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
DODGE & COX 16% $1,856,108,638 79,084,305 Dodge & Cox 31 Dec 2025
FMR LLC 10% -20% $1,181,202,753 -$287,108,530 52,196,321 -20% FMR LLC 31 Dec 2025
BlackRock, Inc. 8.9% +112% $886,598,367 +$443,042,097 44,021,766 +100% BlackRock, Inc. 30 Sep 2025
T. Rowe Price Investment Management, Inc. 6.4% $635,376,116 31,547,970 T. Rowe Price Investment Management, Inc. 30 Sep 2025
DIMENSIONAL FUND ADVISORS LP 4.9% -2% $586,934,341 -$13,290,961 24,527,135 -2.2% Dimensional Fund Advisors LP 31 Mar 2026

As of 31 Dec 2025, 479 institutional investors reported holding 539,036,951 shares of Elanco Animal Health Inc - Common Stock (ELAN). This represents 108% of the company’s total 500,553,776 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Elanco Animal Health Inc - Common Stock (ELAN) together control 90% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Dodge & Cox 16% 79,084,305 -4.4% 0.97% $1,789,677,822
FMR LLC 10% 52,196,321 -20% 0.06% $1,181,202,754
VANGUARD GROUP INC 9.6% 48,059,731 -1.1% 0.02% $1,087,591,712
BlackRock, Inc. 9.3% 46,335,397 +0.34% 0.02% $1,048,570,038
PRIMECAP MANAGEMENT CO/CA/ 9.2% 46,214,088 -7.5% 0.79% $1,045,824,811
T. Rowe Price Investment Management, Inc. 7% 35,227,418 +12% 0.5% $797,197,000
DIMENSIONAL FUND ADVISORS LP 5% 25,082,545 +1.5% 0.12% $567,621,557
STATE STREET CORP 3% 15,050,538 -1.3% 0.01% $340,593,675
Black Creek Investment Management Inc. 2.2% 11,061,216 -11% 12% $250,315,318
GEODE CAPITAL MANAGEMENT, LLC 1.9% 9,425,533 +7.3% 0.01% $213,342,792
UBS Group AG 1.7% 8,672,844 -47% 0.04% $196,266,459
MORGAN STANLEY 1.7% 8,286,608 -19% 0.01% $187,525,955
MILLENNIUM MANAGEMENT LLC 1.6% 8,122,607 +45% 0.13% $183,814,596
MANUFACTURERS LIFE INSURANCE COMPANY, THE 1.5% 7,263,162 -4.2% 0.14% $164,369,893
Nuveen, LLC 1.2% 6,093,489 -14% 0.04% $137,895,656
FULLER & THALER ASSET MANAGEMENT, INC. 1.2% 5,771,622 +16% 0.44% $130,611,795
Clearbridge Investments, LLC 1.1% 5,672,645 -3.8% 0.1% $128,371,956
Invesco Ltd. 0.96% 4,789,037 +336% 0.02% $108,375,907
BARROW HANLEY MEWHINNEY & STRAUSS LLC 0.86% 4,313,086 -14% 0.33% $97,605,136
BRANDES INVESTMENT PARTNERS, LP 0.84% 4,201,864 -29% 0.72% $95,088,183
NORTHERN TRUST CORP 0.82% 4,108,908 -4.3% 0.01% $92,984,588
Bank of New York Mellon Corp 0.78% 3,914,814 -24% 0.02% $88,592,242
CITADEL ADVISORS LLC 0.74% 3,698,126 -24% 0.06% $83,688,592
JUPITER ASSET MANAGEMENT LTD 0.73% 3,633,794 -2.2% 0.66% $82,232,758
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.71% 3,540,728 -9.7% 0.01% $80,126,668

Institutional Holders of Elanco Animal Health Inc - Common Stock (ELAN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 8,495,402 $203,248,851 +$6,090,977 $23.93 84
2025 Q4 539,036,951 $12,199,052,360 -$765,097,720 $22.63 479
2025 Q3 570,844,069 $11,496,298,982 +$680,262,488 $20.14 406
2025 Q2 538,352,937 $7,687,668,693 +$655,647,979 $14.28 362
2025 Q1 494,022,445 $5,187,492,485 +$2,004,620 $10.50 359
2024 Q4 489,345,019 $5,925,862,528 +$26,438,350 $12.11 387
2024 Q3 481,862,274 $7,076,192,785 -$28,345,131 $14.69 384
2024 Q2 482,171,600 $6,957,441,182 +$6,686,922 $14.43 396
2024 Q1 480,177,163 $7,816,997,297 +$26,389,803 $16.28 370
2023 Q4 479,962,841 $7,151,250,374 +$21,579,978 $14.90 349
2023 Q3 481,442,000 $5,409,895,330 +$102,163,765 $11.24 344
2023 Q2 473,375,354 $4,760,610,377 -$67,531,728 $10.06 345
2023 Q1 479,522,703 $4,495,944,050 -$110,942,259 $9.40 384
2022 Q4 481,681,648 $5,908,155,843 +$232,156,887 $12.22 398
2022 Q3 463,043,345 $5,755,609,685 -$196,296,127 $12.41 398
2022 Q2 470,431,046 $9,236,728,928 -$88,523,747 $19.63 421
2022 Q1 473,375,688 $12,362,622,405 -$47,241,309 $26.09 454
2021 Q4 475,123,500 $13,465,426,403 +$218,382,206 $28.38 461
2021 Q3 467,401,656 $14,907,014,269 -$71,757,204 $31.89 435
2021 Q2 468,283,929 $16,250,367,215 +$128,764,524 $34.69 464
2021 Q1 467,015,636 $13,752,652,796 +$242,000,095 $29.45 433
2020 Q4 458,146,787 $14,050,001,284 +$1,375,218,703 $30.67 424
2020 Q3 413,516,389 $11,539,620,540 +$535,290,448 $27.93 348
2020 Q2 396,250,140 $8,506,918,630 -$172,335,832 $21.45 355
2020 Q1 402,762,228 $9,017,316,731 +$571,966,377 $22.39 350
2019 Q4 369,452,160 $10,879,469,608 -$57,025,660 $29.45 390
2019 Q3 371,517,866 $9,877,782,405 -$152,630,501 $26.59 359
2019 Q2 374,935,481 $12,675,665,904 +$446,834,964 $33.80 364
2019 Q1 373,768,060 $11,987,183,816 +$9,247,514,461 $32.07 342
2018 Q4 85,024,329 $2,681,019,350 +$393,741,056 $31.53 164
2018 Q3 71,099,284 $2,480,509,428 +$2,480,239,432 $34.89 153
2016 Q2 0 $0 -$6,000 $23.93 0
2016 Q1 186 $6,000 $32.26 1